Impact of compliance with an enhanced recovery after surgery pathway on patient outcomes in open gynecologic surgery

被引:30
|
作者
Iniesta, Maria D. [1 ]
Lasala, Javier [2 ]
Mena, Gabriel [2 ]
Rodriguez-Restrepo, Andrea [3 ]
Salvo, Gloria [1 ]
Pitcher, Brandelyn [4 ]
Washington, Lakisha D. [1 ]
Harris, Melinda [1 ]
Meyer, Larissa A. [1 ]
Ramirez, Pedro T. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA
[3] No Arizona Univ, Dept Anesthesiol & Perioperat Med, Tucson Campus, Tucson, AZ USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
关键词
ERAS; compliance; gynecologic surgery; postoperative outcomes; ERAS(R) SOCIETY RECOMMENDATIONS; ACUTE KIDNEY INJURY; GUIDELINES; PROTOCOL; CARE;
D O I
10.1136/ijgc-2019-000622
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective The aim of this study was to evaluate if varying levels of compliance with an enhanced recovery after surgery (ERAS) protocol impacted post-operative outcomes (length of stay, complications, readmissions, and re-operations) in gynecologic surgery at a tertiary center. Methods We included 584 patients who had open gynecologic surgery between November 1, 2014 and December 31, 2016. Patients were categorized into subgroups according to their date of surgery from the time of the ERAS protocol implementation. Patients were categorized by their per cent compliance into two groups:<80%versus <greater than or equal to>80%. We analyzed compliance with the elements of the protocol over time and its relation with post-operative outcomes, length of stay, post-operative complications, readmission, and re-operations rates. We modeled the probability of having a post-operative complication within 30 days of surgery as a function of overall compliance. Results Overall compliance was 72.3%. Patients with compliance >= 80% had significantly less complications (P<0.001) and shorter length of stay (P<0.001). Readmission and re-operation rates were not impacted by compliance (P=0.182, P=0.078, respectively). Avoidance of salt water overload, early mobilization, early oral nutrition, and early removal of Foley catheter were significantly associated with less post-operative complications within 30 days. Conclusions Compliance with an ERAS pathway exceeding 80% was associated with lower complication rates and shorter length of stay without impacting on re-operations or readmissions.
引用
收藏
页码:1417 / 1424
页数:8
相关论文
共 50 条
  • [31] The impact of an urogynecologic-specific enhanced recovery after surgery (ERAS) pathway implementation in open prolapse surgery
    Trad, A. Teles Abrao
    Tamhane, P.
    Weaver, A.
    Baker, M. V.
    Visscher, S.
    Borah, D.
    Kalogera, E.
    Klingele, C.
    Gebhart, J.
    Trabuco, E.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (03) : S829 - S829
  • [32] Fast-track Surgery in Real Life: How Patient Factors Influence Outcomes and Compliance With an Enhanced Recovery Clinical Pathway After Colorectal Surgery
    Feroci, Francesco
    Lenzi, Elisa
    Baraghini, Maddalena
    Garzi, Alessia
    Vannucchi, Andrea
    Cantafio, Stefano
    Scatizzi, Marco
    SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 2013, 23 (03): : 259 - 265
  • [33] Sustainability of an enhanced recovery pathway after minimally invasive gynecologic oncology surgery
    Mccracken, Anna
    Kim, Rachel Soyoun
    Laframboise, Stephane
    Maganti, Manjula
    Bernardini, Marcus Q.
    Ferguson, Sarah
    Hogen, Liat
    May, Taymaa
    Mccluskey, Stuart A.
    Bouchard-Fortier, Genevieve
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (05) : 738 - 744
  • [34] A cost analysis of the impact of enhanced recovery after surgery (ERAS) protocol in gynecologic oncology surgery
    Gentry, Z. L.
    Boitano, T. K. L.
    Smith, H. J.
    Russell, J.
    Eads, D.
    Straughn, J. M., Jr.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 211 - 211
  • [35] Impact of Compliance with an Enhanced Recovery After Surgery Program on the Outcomes Among Elderly Patients Undergoing Lumbar Fusion Surgery
    Li, Zhong-En
    Lu, Shi-Bao
    Kong, Chao
    Sun, Wen-Zhi
    Wang, Peng
    Zhang, Si-Tao
    CLINICAL INTERVENTIONS IN AGING, 2020, 15 : 2423 - 2430
  • [36] International validation of Enhanced Recovery After Surgery Society guidelines on enhanced recovery for gynecologic surgery
    Wijk, Lena
    Udumyan, Ruzan
    Pache, Basile
    Altman, Alon D.
    Williams, Laura L.
    Elias, Kevin M.
    McGee, Jake
    Wells, Tiffany
    Gramlich, Leah
    Holcomb, Kevin
    Achtari, Chahin
    Ljungqvist, Olle
    Dowdy, Sean C.
    Nelson, Gregg
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 221 (03) : 237.e1 - 237.e11
  • [37] Acute kidney injury in Enhanced Recovery After Surgery (ERAS) protocols in open gynecologic oncology surgery
    Cowan, Matthew
    Azad, Hooman
    Nakamura, Brad
    Ahmad, Shireen
    Strohl, Anna
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S81 - S81
  • [38] Effectiveness of enhanced recovery after surgery protocol in open gynecologic oncology surgery: A randomized controlled trial
    Chiewhatpong, Phasawee
    Charoenkwan, Kittipat
    Smithiseth, Kannika
    Lapisatepun, Warangkana
    Lapisatepun, Panuwat
    Phimphilai, Mattabhorn
    Muangmool, Tanarat
    Cheewakriangkrai, Chalong
    Suprasert, Prapaporn
    Srisomboon, Jatupol
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 159 (02) : 568 - 576
  • [39] The Benefits of Enhanced Recovery After Surgery (ERAS) Pathway with Quadratus Lumborum Blocks for Gynecologic Surgery Patients
    Lee, Paul
    Eloustaz, Mohamed
    Kim, Michael P.
    Dickerson, Shane
    Brunette, Laurie
    Titus, Micha
    Yu, Valerie
    ANESTHESIA AND ANALGESIA, 2020, 130 : 837 - 837
  • [40] The impact of enhanced recovery after surgery on postoperative outcomes in gynecologic oncology hysterectomies: A community hospital perspective
    Levine, Rachel
    Feehan, Tara
    Hartman, Rachel
    Baron, James
    Miller, Heather
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S251 - S251